Encompass Health Corporation (EHC) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
Encompass Health Corporation cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $455,600,000.00Depreciation and amortization → Operating adjustments reconciliation: $177,700,000.00Stock-based compensation → Operating adjustments reconciliation: $25,300,000.00Accounts payable → Operating adjustments reconciliation: $20,300,000.00Net cash provided by (used in) operating activities of discontinued operations → Operating adjustments reconciliation: $20,300,000.00Other liabilities → Operating adjustments reconciliation: $10,600,000.00Other, net → Operating adjustments reconciliation: $6,800,000.00Deferred tax expense → Operating adjustments reconciliation: $5,400,000.00Loss on early extinguishment of debt → Operating adjustments reconciliation: $3,400,000.00Operating adjustments reconciliation → Net cash from operating activities: $140,100,000.00Operating adjustments reconciliation → Accounts receivable: $63,400,000.00Operating adjustments reconciliation → Other assets: $28,400,000.00Operating adjustments reconciliation → Gain on investments: $22,600,000.00Operating adjustments reconciliation → (Income) loss from discontinued operations, net of tax: $15,300,000.00Proceeds from sale of restricted investments → investing reconciliation: $59,600,000.00investing reconciliation → Purchases of property, equipment, and intangible assets: $382,700,000.00investing reconciliation → Purchases of restricted investments: $54,500,000.00investing reconciliation → Other, net: $8,100,000.00Net cash used in financing activities → financing reconciliation: $179,400,000.00Borrowings on revolving credit facility → financing reconciliation: $670,000,000.00Proceeds from bond issuance → financing reconciliation: $500,000,000.00Other, net → financing reconciliation: $1,100,000.00financing reconciliation → Payments on revolving credit facility: $600,000,000.00financing reconciliation → Principal payments on debt, including pre-payments: $411,800,000.00financing reconciliation → Repurchases of common stock, including fees and expenses: $145,800,000.00financing reconciliation → Distributions paid to noncontrolling interests of consolidated affiliates: $98,100,000.00financing reconciliation → Dividends paid on common stock: $39,200,000.00financing reconciliation → Taxes paid on behalf of employees for shares withheld: $30,900,000.00financing reconciliation → Principal payments under finance lease obligations: $12,900,000.00financing reconciliation → Debt amendment and issuance costs: $11,800,000.00Net cash used in investing activities → investing reconciliation: $385,700,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $102,900,000.00Net cash from operating activities → Cash sources and uses: $595,700,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $133,500,000.00Cash sources and uses → Net cash used in investing activities: $385,700,000.00Cash sources and uses → Net cash used in financing activities: $179,400,000.00Net income: $455,600,000.00Net income+$455.60 M(Income) loss from discontinued operations, net of tax: -$15,300,000.00Discontinued operations, net−$15.30 MDepreciation and amortization: $177,700,000.00Depreciation & amortization+$177.70 MLoss on early extinguishment of debt: $3,400,000.00Debt extinguishment gain & loss+$3.40 MStock-based compensation: $25,300,000.00Stock-based compensation+$25.30 MDeferred tax expense: $5,400,000.00Deferred income taxes+$5.40 MGain on investments: -$22,600,000.00Investment gain & loss−$22.60 MOther, net: $6,800,000.00Other non-cash items+$6.80 MAccounts receivable: -$63,400,000.00Accounts receivable−$63.40 MOther assets: -$28,400,000.00Other operating assets−$28.40 MAccounts payable: $20,300,000.00Accounts payable+$20.30 MOther liabilities: $10,600,000.00Other operating liabilities+$10.60 MNet cash provided by (used in) operating activities of discontinued operations: $20,300,000.00Discontinued operations cash+$20.30 MNet cash from operating activities: $595,700,000.00Operating cash+$595.70 MOperating adjustments reconciliation: $269,800,000.00Proceeds from bond issuance: $500,000,000.00Senior debt issued+$500.00 MPrincipal payments on debt, including pre-payments: -$411,800,000.00Senior debt repaid−$411.80 MBorrowings on revolving credit facility: $670,000,000.00Long-term credit line borrowings+$670.00 MPayments on revolving credit facility: -$600,000,000.00Long-term credit line repayments−$600.00 MPrincipal payments under finance lease obligations: -$12,900,000.00Finance lease payments−$12.90 MDebt amendment and issuance costs: -$11,800,000.00Debt issuance costs−$11.80 MRepurchases of common stock, including fees and expenses: -$145,800,000.00Common stock repurchases−$145.80 MDividends paid on common stock: -$39,200,000.00Common dividends paid−$39.20 MDistributions paid to noncontrolling interests of consolidated affiliates: -$98,100,000.00Paid to noncontrolling interests−$98.10 MTaxes paid on behalf of employees for shares withheld: -$30,900,000.00Stock-award tax withholding−$30.90 MOther, net: $1,100,000.00Other financing, net+$1.10 MNet cash used in financing activities: -$179,400,000.00. Cash required to fund net payments.Financing cash−$179.40 Mfinancing reconciliation: $1,350,500,000.00Purchases of property, equipment, and intangible assets: -$382,700,000.00Capital expenditures−$382.70 MProceeds from sale of restricted investments: $59,600,000.00Restricted investments sold+$59.60 MPurchases of restricted investments: -$54,500,000.00Restricted investment purchases−$54.50 MOther, net: -$8,100,000.00Other investing, net−$8.10 MNet cash used in investing activities: -$385,700,000.00. Cash required to fund net payments.Investing cash−$385.70 Minvesting reconciliation: $445,300,000.00Cash sources and uses: $698,600,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $102,900,000.00Beginning cash$102.90 MEnding cash: Cash, cash equivalents, and restricted cash: $133,500,000.00Ending cash$133.50 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$213.00 MOperating cash − cash spent on productive assetsCash flow / Net income1.31×Operating cash flow ÷ net incomeNet cash change+$30.60 MEnding cash − beginning cash
Chart details

Encompass Health Corporation cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
102,900,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
595,700,000 US dollars. Net cash provided.
Net income
455,600,000 US dollars
(Income) loss from discontinued operations, net of tax
negative 15,300,000 US dollars
Depreciation and amortization
177,700,000 US dollars
Loss on early extinguishment of debt
3,400,000 US dollars
Stock-based compensation
25,300,000 US dollars
Deferred tax expense
5,400,000 US dollars
Gain on investments
negative 22,600,000 US dollars
Other, net
6,800,000 US dollars
Accounts receivable
negative 63,400,000 US dollars
Other assets
negative 28,400,000 US dollars
Accounts payable
20,300,000 US dollars
Other liabilities
10,600,000 US dollars
Net cash provided by (used in) operating activities of discontinued operations
20,300,000 US dollars
Investing activities
negative 385,700,000 US dollars. Net cash used.
Purchases of property, equipment, and intangible assets
negative 382,700,000 US dollars
Proceeds from sale of restricted investments
59,600,000 US dollars
Purchases of restricted investments
negative 54,500,000 US dollars
Other, net
negative 8,100,000 US dollars
Financing activities
negative 179,400,000 US dollars. Net cash used.
Proceeds from bond issuance
500,000,000 US dollars
Principal payments on debt, including pre-payments
negative 411,800,000 US dollars
Borrowings on revolving credit facility
670,000,000 US dollars
Payments on revolving credit facility
negative 600,000,000 US dollars
Principal payments under finance lease obligations
negative 12,900,000 US dollars
Debt amendment and issuance costs
negative 11,800,000 US dollars
Repurchases of common stock, including fees and expenses
negative 145,800,000 US dollars
Dividends paid on common stock
negative 39,200,000 US dollars
Distributions paid to noncontrolling interests of consolidated affiliates
negative 98,100,000 US dollars
Taxes paid on behalf of employees for shares withheld
negative 30,900,000 US dollars
Other, net
1,100,000 US dollars
Operating adjustment reconciliation
269,800,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
1,350,500,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
445,300,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
133,500,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
698,600,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
30,600,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.31×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
595,700,000 US dollars. Operating cash flow used in the free cash flow calculation.
cash spent on productive assets
382,700,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
213,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $140.10M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash spent on productive assets equals free cash flow: 595,700,000 US dollars minus 382,700,000 US dollars equals 213,000,000 US dollars.
Encompass Health Corporation (EHC) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!